# Gilles Vassal

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gilles-vassal/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,543 |
| Field | Neuroblastoma Research and Treatments |
| h-index | 72 |
| i10-index | 278 |
| Last Known Institution | Université Paris-Saclay |
| OpenAlex ID | https://openalex.org/A5067202962 |
| ORCID iD | https://orcid.org/0000-0003-1780-8869 |
| Works | 714 |

## Researcher papers

- [Risk of Secondary Leukemia After a Solid Tumor in Childhood According to the Dose of Epipodophyllotoxins and Anthracyclines: A Case-Control Study by the Société Française d’Oncologie Pédiatrique](https://scholariq.org/papers/risk-of-secondary-leukemia-after-a-solid-tumor-in-childhood-according-to-the/)
- [Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer](https://scholariq.org/papers/diverse-resistance-mechanisms-to-the-third-generation-alk-inhibitor-lorlatinib/)

## Researcher topics

- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Université Paris-Saclay](https://scholariq.org/institutions/universite-paris-saclay/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.